Agents Intervening Against Delirium in Intensive Care Unit
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
Delirium is a frequent condition in the Intensive Care Unit (ICU) with no existing
evidence-based treatment. The aim of the AID-ICU study is to assess the benefits and harms of
haloperidol treatment for the management of ICU acquired delirium.
Phase:
Phase 4
Details
Lead Sponsor:
Zealand University Hospital
Collaborators:
Centre for Research in Intensive Care (CRIC) Copenhagen Trial Unit, Center for Clinical Intervention Research Scandinavian Critical Care Trials Group The Danish Centre of Applied Social Science (VIVE)